TickerFactsScreenerDevelopers

Intellia Therapeutics, Inc. (NTLA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $2.55M2016: $6.17M2017: $10.09M2018: $6.36M2019: $6.79M2020: $3.58M2021: $12.76M2022: $13.56M2023: $13.98M2024: $5.78M2025: $1.13M$1.13M
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.13M-80.5%
2024$5.78M-58.7%
2023$13.98M+3.1%
2022$13.56M+6.3%
2021$12.76M+255.8%
2020$3.58M-47.2%
2019$6.79M+6.9%
2018$6.36M-37.0%
2017$10.09M+63.7%
2016$6.17M+141.4%
2015$2.55M—